A Certificate of Analysis (COA) is the primary document a laboratory uses to characterize a research peptide before it enters any experimental workflow. It reports the analytical evidence behind two core questions: is the material the correct compound (identity), and how much of the sample is the intended peptide versus impurities (purity and content). For research-use-only peptides, the COA is the bridge between a vial of lyophilized powder and reproducible, interpretable data. This guide explains, in laboratory terms, how to read the most common sections of a peptide COA and why analysts treat high purity as a prerequisite for sound experimental design.
What a Certificate of Analysis is
A COA is a batch-specific analytical record produced after a peptide is synthesized and purified. Because it is tied to a specific lot, two vials of the same compound from different batches can carry different COAs. A complete certificate typically lists the peptide name and sequence, molecular formula and theoretical molecular weight, the lot or batch number, the analytical methods applied, and the results of those methods. Researchers examine the COA to confirm that the supplied material matches what the experimental protocol assumes, and to document provenance for their own records and publications.
Key fields to confirm first
- Sequence and molecular weight: the one-letter or three-letter amino acid sequence and the calculated monoisotopic or average mass, which the mass spectrometry result is checked against.
- Lot/batch number: uniquely ties the certificate to the physical material on hand.
- Appearance and form: usually a white to off-white lyophilized powder, noted for visual cross-checking.
How researchers read identity by mass spectrometry
Mass spectrometry (MS) establishes identity. Techniques such as ESI-MS (electrospray ionization) or MALDI-TOF measure the mass-to-charge ratio of the ionized peptide, allowing the observed molecular weight to be compared with the theoretical value derived from the sequence. When the measured mass aligns with the expected mass within the instrument's tolerance, it supports the conclusion that the synthesized molecule is the intended peptide rather than a truncated, deleted, or otherwise incorrect sequence. Analysts look for the COA to display both the theoretical and the observed mass so the agreement can be verified directly. Mass spectrometry confirms what the compound is; it does not, on its own, quantify how much of the sample is that compound.
How researchers read purity by HPLC
High-performance liquid chromatography (HPLC) addresses purity. In a reversed-phase HPLC run, components of the sample separate as they pass through a column and are detected, typically by UV absorbance. The resulting chromatogram shows a series of peaks; the main peak corresponds to the target peptide, and smaller peaks represent impurities such as synthesis by-products or closely related sequences. Purity is reported as the area of the main peak expressed as a percentage of the total integrated peak area. A value of, for example, 99% indicates that the target peptide accounts for that share of the detectable, UV-absorbing material under the analytical conditions used. Researchers note that HPLC purity is a relative measure of chromatographic peak area and reflects the specific method, column, and detection wavelength described on the certificate.
Why purity matters for reproducibility
Impurities introduce uncontrolled variables. Two batches nominally of the same peptide but with different impurity profiles can behave differently in an assay, complicating comparison across experiments and across laboratories. Because impurities can vary unpredictably from lot to lot, higher purity narrows the range of unknowns and helps ensure that an observed result is attributable to the intended molecule. This is why many research groups prefer material characterized at >=99% by HPLC: it supports cleaner data, easier troubleshooting, and more defensible reproducibility when work is repeated or published.
Net peptide content versus purity
HPLC purity and net peptide content are distinct measurements, and conflating them is a common error. Purity describes the proportion of the peptide relative to other peptide-related species. Net peptide content describes the fraction of the total dry mass in the vial that is actually peptide, with the remainder consisting of non-peptide components such as residual water, counter-ions (for example, trifluoroacetate or acetate salts), and bound moisture. A peptide can be 99% pure by HPLC yet represent a smaller percentage of the vial's total weight once salts and water are accounted for. Researchers consult net peptide content, often determined by amino acid analysis or nitrogen analysis, when accurate mass accounting matters for an experimental plan.
Research considerations: storage and handling
A strong COA characterizes the material as received; maintaining that quality is a function of handling. Lyophilized research peptides are generally stored desiccated and frozen, protected from light, with attention to minimizing freeze-thaw cycles after any reconstitution in a laboratory context. Because peptides can be sensitive to moisture, temperature, and oxidation, careful storage helps preserve the identity and purity the certificate documents. Analysts treat the COA as a baseline record and pair it with sound laboratory handling so that the material studied later still corresponds to the material characterized at release.
Peptiva Research Labs supplies this and other research peptides HPLC-verified and accompanied by a batch-specific Certificate of Analysis documenting identity and purity. All materials are provided For Research Use Only, not for human or veterinary use.
